home / stock / tffp / tffp news

TFFP News and Press, TFF Pharmaceuticals Inc - Ordinary Shares From 08/14/23

Stock Information
Company Name: TFF Pharmaceuticals Inc - Ordinary Shares
Stock Symbol: TFFP
Market: NASDAQ
Website: tffpharma.com
Menu
TFFP TFFP Quote TFFP Short TFFP News TFFP Articles TFFP Message Board
Get TFFP Alerts

News, Short Squeeze, Breakout and More Instantly...
TFFP - Notable earnings before Tuesday's open

2023-08-14 10:17:31 ET Major earnings expected before the bell on Tuesday include: Cardinal Health ( CAH ) The Home Depot ( HD ) Jumia Technologies ( JMIA ) Seadrill ( SDRL ) Sea ( SE ) For further details see: Notable earnings before Tues...
TFFP - TFF Pharmaceuticals to Hold Second Quarter 2023 Financial and Business Results Conference Call on August 15, 2023

FORT WORTH, Texas, Aug. 09, 2023 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology platform, today announced tha...

TFFP - TFF Pharmaceuticals Inc. and Uniphar Durbin Ireland Ltd. Announce the Opening of an Expanded Access Program for Voriconazole Inhalation Powder (TFF VORI) for the Treatment of Pulmonary Aspergillosis and Other Voriconazole Responsive Fungal Pulmonary Infec

Voriconazole Inhalation Powder (TFF VORI) is an investigational, inhaled formulation of voriconazole developed using TFF Pharmaceuticals Thin Film Freezing technology that is currently being evaluated in a Phase 2 trial for the treatment of invasive pulmonary Aspergillosis (IPA). TFF VORI is not ...

TFFP - TFF Pharmaceuticals Awarded $2.97 Million to Develop Universal Influenza Vaccine

National Institute of Health/National Institute of Allergy and Infectious Disease Direct to Phase II SBIR Grant Will Fund Preclinical and IND Enabling Studies on a Shelf-Stable Mucosal Delivered Universal Flu Vaccine Using Thin Film Freezing Significant Funding a Result of a Multi-Year ...
TFFP - TFF Pharmaceuticals to Participate in the 2023 Jefferies Healthcare Conference

FORT WORTH, Texas, May 23, 2023 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing technology platform, today announced that CEO H...

TFFP - TFF Pharmaceuticals GAAP EPS of -$0.19 beats by $0.01

2023-05-11 17:49:06 ET TFF Pharmaceuticals press release ( NASDAQ: TFFP ): Q1 GAAP EPS of -$0.19 beats by $0.01 . As of March 31, 2023, TFF Pharmaceuticals reported cash and cash equivalents of $12.2 million. Shares +3.57% AH. For further details see: ...

TFFP - TFF Pharmaceuticals Provides Corporate Update and Reports First Quarter 2023 Financial Results

Initial Phase 2 data for TFF VORI and TFF TAC expected later this year Expanded compassionate use program for TFF VORI Entered into CRADA with National Institute of Environmental Health Sciences Extended contract with Leidos providing additional funding for TFF’s ...
TFFP - TFF Pharmaceuticals Enters into CRADA with the National Institute of Environmental Health Sciences to Develop Dry Powder Formulations of Hyaluronan to Prevent and Treat Respiratory Diseases

FORT WORTH, Texas, May 04, 2023 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP) (“the Company”), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology platf...

TFFP - TFF Pharmaceuticals Receives Additional Funding from Leidos to Advance Next-Generation Personalized Protective Biosystems under the DARPA PPB Program

FORT WORTH, Texas, May 01, 2023 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP) (“the Company”), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology platf...

TFFP - TFF Pharmaceuticals Reports Fourth Quarter 2022 and Full Year 2022 Financial Results

FORT WORTH, Texas, March 07, 2023 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP) (“the Company”), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology pla...
Previous 10 Next 10